Complex Karyotype in CLL-How to Count Cytogenetic Aberrations Consistently and Efficiently

Area of Science:

• Hematology
• Genetics
• Oncology

Background:

• Complex karyotype (CK) is a significant adverse prognostic marker in chronic lymphocytic leukemia (CLL).
• Discrepancies in counting chromosomal aberrations affect CK classification and patient risk stratification.
• Standardization of CK assessment is crucial for reliable prognostic evaluation in CLL.

Purpose of the Study:

• To systematically compare two distinct methods for counting chromosomal aberrations in CLL.
• To evaluate the impact of different counting strategies on CK classification and prognostic stratification.
• To recommend a standardized and unambiguous method for determining CK status in CLL.

Main Methods:

• Analysis of chromosome banding data from 1605 CLL patients.
• Comparison of the Jondreville et al. counting method with the International System for Human Cytogenomic Nomenclature (ISCN) method.
• Evaluation of aberration counting across all clones versus within the most complex clone.

Main Results:

• The Jondreville et al. and ISCN methods yielded different CK classifications in 7.5% of cases.
• Both methods demonstrated similar prognostic performance for ambiguous cases.
• Counting aberrations in the most complex clone improved stratification for 3.5% of differentially classified cases.

Conclusions:

• The Jondreville et al. method is recommended for CK determination in CLL due to its simplicity and clarity.
• Counting aberrations solely within the most complex clone provides superior risk stratification.
• Standardizing CK assessment using the proposed method will enhance prognostic accuracy in CLL management.